Fiera Capital Corp Sells 11,553 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC)

Fiera Capital Corp cut its position in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) by 2.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 381,644 shares of the company's stock after selling 11,553 shares during the quarter. Fiera Capital Corp owned 1.22% of iRhythm Technologies worth $28,333,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of IRTC. SeaCrest Wealth Management LLC boosted its holdings in shares of iRhythm Technologies by 7.6% during the second quarter. SeaCrest Wealth Management LLC now owns 2,125 shares of the company's stock worth $229,000 after purchasing an additional 150 shares during the period. Ascent Group LLC raised its position in iRhythm Technologies by 4.6% during the first quarter. Ascent Group LLC now owns 3,980 shares of the company's stock valued at $462,000 after acquiring an additional 175 shares in the last quarter. Swiss National Bank raised its position in iRhythm Technologies by 0.3% during the first quarter. Swiss National Bank now owns 60,500 shares of the company's stock valued at $7,018,000 after acquiring an additional 200 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of iRhythm Technologies by 79.6% in the second quarter. Nisa Investment Advisors LLC now owns 625 shares of the company's stock valued at $67,000 after purchasing an additional 277 shares during the period. Finally, Arizona State Retirement System raised its position in shares of iRhythm Technologies by 3.4% in the second quarter. Arizona State Retirement System now owns 8,711 shares of the company's stock valued at $938,000 after purchasing an additional 287 shares during the period.

iRhythm Technologies Price Performance

Shares of iRhythm Technologies stock traded down $2.28 during trading on Friday, reaching $86.48. The company's stock had a trading volume of 462,472 shares, compared to its average volume of 779,796. The stock has a 50-day moving average price of $70.91 and a two-hundred day moving average price of $84.33. The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00. iRhythm Technologies, Inc. has a one year low of $55.92 and a one year high of $124.11. The stock has a market capitalization of $2.71 billion, a P/E ratio of -17.79 and a beta of 1.23.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported ($1.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.71). iRhythm Technologies had a negative net margin of 26.90% and a negative return on equity of 120.86%. The business had revenue of $147.54 million during the quarter, compared to the consensus estimate of $146.69 million. During the same period in the prior year, the firm earned ($0.89) earnings per share. The business's quarterly revenue was up 18.4% compared to the same quarter last year. As a group, sell-side analysts anticipate that iRhythm Technologies, Inc. will post -3.44 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on IRTC shares. Oppenheimer lowered their price objective on shares of iRhythm Technologies from $165.00 to $145.00 and set an "outperform" rating on the stock in a research note on Friday, August 2nd. The Goldman Sachs Group began coverage on shares of iRhythm Technologies in a research note on Friday, October 4th. They set a "neutral" rating and a $78.00 price target on the stock. Citigroup reduced their target price on shares of iRhythm Technologies from $135.00 to $110.00 and set a "buy" rating on the stock in a research note on Thursday, August 22nd. Truist Financial boosted their target price on shares of iRhythm Technologies from $80.00 to $95.00 and gave the company a "buy" rating in a research note on Tuesday, October 22nd. Finally, Robert W. Baird reduced their target price on shares of iRhythm Technologies from $100.00 to $79.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $108.50.

Insider Activity at iRhythm Technologies

In related news, CEO Quentin S. Blackford sold 16,145 shares of iRhythm Technologies stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $77.41, for a total value of $1,249,784.45. Following the completion of the transaction, the chief executive officer now directly owns 159,929 shares of the company's stock, valued at $12,380,103.89. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other iRhythm Technologies news, CEO Quentin S. Blackford sold 16,145 shares of the business's stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $77.41, for a total transaction of $1,249,784.45. Following the completion of the sale, the chief executive officer now directly owns 159,929 shares of the company's stock, valued at approximately $12,380,103.89. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Abhijit Y. Talwalkar acquired 6,664 shares of the company's stock in a transaction on Monday, November 4th. The shares were purchased at an average cost of $75.16 per share, with a total value of $500,866.24. Following the completion of the acquisition, the director now directly owns 18,941 shares in the company, valued at approximately $1,423,605.56. The trade was a 0.00 % increase in their position. The disclosure for this purchase can be found here. 0.68% of the stock is currently owned by company insiders.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.